HARBOUR HCAB PLUS

Welcome to the Brand page for “HARBOUR HCAB PLUS”, which is offered here for Diagnostic preparations for medical purposes; drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; tumor suppressing agents; pharmaceutical products for the prevention and treatment of cancer; medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; chemical preparations for pharmaceutical or medical purposes, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor;technical research in the field of pharmaceutical studies; research and development of new products for others; scientific investigations for medical purposes; development of pharmaceutical preparations and medicines; medical laboratory services; scientific research in the nature of conducting clinical trials for others; medical research; biological research; biochemical research and analysis; testing of pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “HARBOUR HCAB PLUS” is believed to be currently owned by “Harbour Antibodies U.S., Inc.”